US Bancorp
RIGL icon

US Bancorp’s Rigel Pharmaceuticals RIGL Stock Holding History

US Bancorp’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-4,677
Closed -$87.6K – 4238
2025
Q2 		$87.6K Sell
4,677
-443
-9% -$8.4K ﹤0.01% 2491
2025
Q1 		$92.1K Buy
5,120
+1,868
+57% +$37.9K ﹤0.01% 2436
2024
Q4 		$54.7K Buy
3,252
+12
+0.4% +$230 ﹤0.01% 2696
2024
Q3 		$52.4K Hold
3,240
– – ﹤0.01% 2715
2024
Q2 		$26.6K Sell
3,240
-200
-6% -$2.09K ﹤0.01% 2948
2024
Q1 		$50.9K Sell
3,440
-1,269
-27% -$17.1K ﹤0.01% 2680
2023
Q4 		$68.3K Buy
+4,709
New +$48.2K ﹤0.01% 2509
2021
Q4 		– Sell
-99
Closed -$4K – 4205
2021
Q3 		$4K Hold
99
– – ﹤0.01% 3727
2021
Q2 		$4K Hold
99
– – ﹤0.01% 3675
2021
Q1 		$3K Hold
99
– – ﹤0.01% 3635
2020
Q4 		$3K Buy
+99
New +$2.87K ﹤0.01% 3517

Other funds holding RIGL

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
CLGM
Capitolis Liquid Global Markets New York $15.7B AUM 30.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return